Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)

Trial Profile

Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 May 2018

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Retinal disorders
  • Focus Adverse reactions
  • Acronyms ARRT
  • Most Recent Events

    • 09 May 2018 Status changed from not yet recruiting to recruiting.
    • 23 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top